Advance Search
JI Weiqi, WANG Yanyan, ZHANG Shifang. Effect of nebulized inhalation of budesonide combined with intravenous injection of dexamethasone in the treatment of preterm infants with bronchopulmonary dysplasia[J]. Journal of Clinical Medicine in Practice, 2024, 28(14): 101-104. DOI: 10.7619/jcmp.20240964
Citation: JI Weiqi, WANG Yanyan, ZHANG Shifang. Effect of nebulized inhalation of budesonide combined with intravenous injection of dexamethasone in the treatment of preterm infants with bronchopulmonary dysplasia[J]. Journal of Clinical Medicine in Practice, 2024, 28(14): 101-104. DOI: 10.7619/jcmp.20240964
shu

Effect of nebulized inhalation of budesonide combined with intravenous injection of dexamethasone in the treatment of preterm infants with bronchopulmonary dysplasia

  • 1.

    Department of Neonatology, Zhangjiakou Maternal and Child Health Care Hospital in Hebei Province, Zhangjiakou, Hebei, 075000

  • 2.

    Department of Gynecology and Obstetrics, Zhangjiakou Maternal and Child Health Care Hospital in Hebei Province, Zhangjiakou, Hebei, 075000

More Information
  • Received Date: March 07, 2024
  • Revised Date: May 23, 2024
  • Available Online: July 19, 2024
    Graphical Abstract
    • Abstract
  • Objective 

    To investigate the efficacy and safety of nebulized inhalation of budesonide combined with intravenous injection of dexamethasone in the treatment of preterm infants with bronchopulmonary dysplasia (BPD).

    Methods 

    A total of 130 preterm infants with BPD were randomly divided into control group (n=65) and experimental group (n=65). The control group received dexamethasone acetate injection on the basis of conventional treatment, while the experimental group was treated with nebulized inhalation of budesonide suspension on the basis of the control group, and both groups were treated continuously for 10 days. The oxygen inhalation time, mechanical ventilation time, hospitalization time, clinical efficacy, and adverse reactions were compared between the two groups, and the BPD grading was also compared between the two groups at 36 weeks of corrected gestational age or at discharge.

    Results 

    After treatment, the oxygen inhalation time, mechanical ventilation time, and hospitalization time in theexperimental group were shorter than those in the control group; the BPD grading in the experimental group was better than that in the control group; the clinical total effective rate in the experimental group was 89.23%, which was higher than 69.23% in the control group; all the between-group differences mentioned above were statistically significant (P < 0.05). There was no significant difference in the incidence of adverse reactions between the two groups (P>0.05).

    Conclusion 

    Nebulized inhalation of budesonide combined with intravenous injection of dexamethasone is safe and effective in treating preterm infants with BPD, which can significantly shorten oxygen inhalation time, mechanical ventilation time and hospitalization time, and improve disease grading.

    • FullText(HTML)
    • References (19)
  • [1]
    DELARA M, CHAUHAN B F, LE M L, et al. Efficacy and safety of pulmonary application of corticosteroids in preterm infants with respiratory distress syndrome: a systematic review and meta-analysis[J]. Arch Dis Child Fetal Neonatal Ed, 2019, 104(2): F137-F144. doi: 10.1136/archdischild-2017-314046
    [2]
    ZHOU J G, BA Y, DU Y, et al. The etiology of neonatal intensive care unit death in extremely low birth weight infants: a multicenter survey in China[J]. Am J Perinatol, 2021, 38(10): 1048-1056. doi: 10.1055/s-0040-1701611
    [3]
    李卓娅, 宋红, 宋焕清, 等. 氨基末端脑钠肽前体水平在早产儿支气管肺发育不良中的临床价值[J]. 实用临床医药杂志, 2022, 8(10): 83-87, 96. doi: 10.7619/jcmp.20220135
    [4]
    宗方汝, 张晶卉, 李文. 雾化吸入布地奈德治疗超早早产儿支气管肺发育不良效果观察[J]. 山东医药, 2021, 61(6): 10-13. doi: 10.3969/j.issn.1002-266X.2021.06.003
    [5]
    王立玲. 应用肺动脉加速时间对支气管肺发育不良早产儿肺血管病变的评估[D]. 山东: 山东大学, 2022.
    [6]
    邵肖梅, 叶鸿瑁, 丘小汕. 实用新生儿学[M]. 5版. 北京: 人民卫生出版社, 2019: 596-601.
    [7]
    李瑞华. 观察地塞米松联合氨溴索治疗早产儿支气管肺发育不良的临床效果[J]. 海峡药学, 2018, 30(2): 221-222. doi: 10.3969/j.issn.1006-3765.2018.02.128
    [8]
    黎江, 陈铁强, 吴敏, 等. 布地奈德雾化吸入治疗支气管肺发育不良的疗效观察[J]. 医学临床研究, 2020, 37(5): 652-654. doi: 10.3969/j.issn.1671-7171.2020.05.004
    [9]
    黄淑贤. 布地奈德雾化吸入治疗对早产儿支气管肺发育不良疗效与治疗安全性的研究[J]. 当代医药论丛, 2023, 21(19): 123-126. doi: 10.3969/j.issn.2095-7629.2023.19.041
    [10]
    徐倩, 张顺先, 罗立荣, 等. 布地奈德雾化吸入对早产儿支气管肺发育不良及1岁时智能发育的影响[J]. 公共卫生与预防医学, 2021, 7(2): 77-80. doi: 10.3969/j.issn.1006-2483.2021.02.018
    [11]
    王惠颖, 杨波, 高翔羽. 布地奈德预防支气管肺发育不良研究进展[J]. 中华新生儿科杂志, 2021, 36(3): 74-77. doi: 10.3760/cma.j.issn.2096-2932.2021.03.020
    [12]
    邓兴强. 雾化吸入布地奈德治疗婴儿支气管肺发育不良(BPD)的临床疗效[J]. 养生保健指南, 2021(47): 15-16. https://www.cnki.com.cn/Article/CJFDTOTAL-EKYX201909010.htm
    [13]
    闫振霞. 布地奈德持续喷入与气管内滴入对新生儿呼吸窘迫综合征疗效分析[J]. 山西医药杂志, 2021, 50(22): 3168-3171. doi: 10.3969/j.issn.0253-9926.2021.22.026
    [14]
    于兆艳. 布地奈德气管内滴入联合机械通气在预防极低出生体质量早产儿支气管肺发育不良中的应用[J]. 河南医学研究, 2021, 30(11): 2015-2017. doi: 10.3969/j.issn.1004-437X.2021.11.031
    [15]
    唐国熙. 布地奈德联合肺表面活性物质对呼吸窘迫综合征早产儿支气管肺发育不良的预防效果[J]. 临床合理用药杂志, 2021, 14(36): 127-130. https://www.cnki.com.cn/Article/CJFDTOTAL-PLHY202136044.htm
    [16]
    胡渝, 廖志伟, 肖小星. 糖皮质激素治疗早产儿支气管肺发育不良的临床效果[J]. 中国医学创新, 2023, 20(23): 36-39. doi: 10.3969/j.issn.1674-4985.2023.23.009
    [17]
    刘思宇, 段江. 糖皮质激素防治早产儿支气管肺发育不良的争议[J]. 中国小儿急救医学, 2022, 29(6): 423-427. doi: 10.3760/cma.j.issn.1673-4912.2022.06.005
    [18]
    董梦园. 雾化吸入布地奈德预防早产儿支气管肺发育不良的临床研究[D]. 郑州: 郑州大学, 2021.
    [19]
    刘燕丽, 郭平, 赖卓莉. 布地奈德吸入治疗早产儿支气管肺发育不良的疗效及对其血气指标和体质量的影响[J]. 医学食疗与健康, 2022, 20(9): 84-87. https://www.cnki.com.cn/Article/CJFDTOTAL-YXSL202209025.htm
    • Related Articles

  • Related Articles

    [1]LIU Jia, FAN Chunguang, SUN Likui, ZHAO Zenglin. Expression changes of interleukin-1α and interleukin-8 in vitro skin stimulation test of medical devices for medical devices with reconstructed human epidermis model[J]. Journal of Clinical Medicine in Practice, 2022, 26(11): 18-21,33. DOI: 10.7619/jcmp.20214815
    [2]ZHANG Xiaodan, XU Yanyan, MA Tiankui, ZHU Yonghong, FAN Qiuling. Research progress of interleukin-17 and interleukin-35 in autoimmune diseases[J]. Journal of Clinical Medicine in Practice, 2022, 26(10): 125-129. DOI: 10.7619/jcmp.20220266
    [3]WANG Qingling, ZHAO Cheng, YI Lisha. Relationships between serum human kallikrein 10 level and clinicopathological characteristics as well as the efficacy of chemotherapy in patients with ovarian cancer[J]. Journal of Clinical Medicine in Practice, 2022, 26(1): 62-66. DOI: 10.7619/jcmp.20213739
    [4]FAN Wen. Efficacy of domperidone combined with Kangfuxin Fluid in treating reflux esophagitis[J]. Journal of Clinical Medicine in Practice, 2020, 24(21): 22-24,28. DOI: 10.7619/jcmp.202021007
    [5]ZHOU Xuehong, ZHANG Jing. Research progress on the correlation between interleukin-6, interleukin-17 and acute myocardial infarction[J]. Journal of Clinical Medicine in Practice, 2020, 24(1): 128-132. DOI: 10.7619/jcmp.202001033
    [6]LIU Zhiguo, WANG Huachun, CHEN Jian, LIU Fengying, WANG Zhen, WANG Qingran, WANG Gang. Expression and clinical significance of IL-10, IL-17 and IFN-γ in infants with Kawasaki disease[J]. Journal of Clinical Medicine in Practice, 2015, (11): 64-66. DOI: 10.7619/jcmp.201511019
    [7]WEI Xuefei, XU Pei, CHEN Zairong, GUO Wanhua. Expressions and significance of serum IFN-γ,IL-4, IL-6 and IL-10 in treatment of patients with renal cell carcinoma[J]. Journal of Clinical Medicine in Practice, 2015, (7): 68-70. DOI: 10.7619/jcmp.201507019
    [8]SU Baofeng, LI Yinfang, ZHANG Li. Expression and clinical significance of interleukin-4, interleukin-8, and interleukin-9 in the serum of children with bronchial asthma[J]. Journal of Clinical Medicine in Practice, 2014, (19): 91-93. DOI: 10.7619/jcmp.201419027
    [9]QIU Zhenqin, DU Zhongde, XU Jiagang. Influence of Danhong injection on the level of serum interleukin-6 and Interleukin-10 in patients with acute cerebral infarction[J]. Journal of Clinical Medicine in Practice, 2014, (19): 17-19. DOI: 10.7619/jcmp.201419006
    [10]LIU Wei, LIU Gang, LENG Junfeng. Effects of different dosage of compound indigo granule on serum IL-6 and IL-10 in rat model of ulcerative colitis[J]. Journal of Clinical Medicine in Practice, 2014, (19): 4-6. DOI: 10.7619/jcmp.201419002

  • Cited by

    Periodical cited type(6)

    1. 刘明香，彭灿，吴秋萍，韦松玲. 神经外科重症监护室患者的疼痛管理策略与护理实践. 中华神经外科疾病研究杂志. 2024(05): 54-56 .
    2. 成茜，李正明，杨梦兰，卢婷婷，杨艳. 基于色彩心理学理念的系统化护理模式对蛛网膜下腔出血患者心理状态和生存质量的影响. 中国医药导报. 2023(17): 161-165 .
    3. 赵晓丹. 神经外科术后疼痛管理中应用综合性疼痛护理的效果及对生活质量的影响. 河北医药. 2022(19): 3031-3034 .
    4. 袁青春. 基于健康信念的干预模式联合规范化疼痛管理对腹腔镜胆囊切除术患者的影响观察. 现代诊断与治疗. 2022(24): 3779-3781 .
    5. 程晶晶，赵萍，李莉，卢伟伟，陈丹. 个体化团队护理模式在自发性蛛网膜下腔出血患者中的临床应用. 中国医刊. 2021(04): 458-461 .
    6. 孙可心. 咪达唑仑联合芬太尼对重症蛛网膜下腔出血患者脑代谢的影响. 中国当代医药. 2021(31): 99-102 .

    Other cited types(0)

Catalog

    Get Citation
    PDF
    XML
    Article views (153) PDF downloads (2) Cited by(6)
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    © 2020 《实用临床医药杂志》编辑部

    Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807

    苏公网安备 32100302010246号

    Supported by: Beijing Renhe Information Technology Co., Ltd.   Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return